# Stereotaxis to acquire Robocath

Stereotaxis has entered into a definitive agreement to acquire Robocath, a venture-backed innovator of robotic technologies for interventional cardiology and neurointerventions. The acquisition strengthens Stereotaxis' position in endovascular procedures.

- Type: Acquisition
- Announced: 2026-04-15
- Where: Rouen, France, France
- Value: $45.0M
- Status: announced
- Products: surgical robotics for endovascular intervention, R-One+ robotic system for percutaneous coronary interventions
- Sectors: [Automation and Robotics](https://endata.com/sectors/automation-robotics.md), [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Robocath](https://endata.com/companies/46844.md) (target)
- [Stereotaxis](https://endata.com/companies/77460.md) (acquirer)

## Sources

- [stereotaxis.gcs-web.com](https://stereotaxis.gcs-web.com/news-releases/news-release-details/stereotaxis-announces-definitive-agreement-acquire-robocath/), 2026-04-15: "Robocath represents a highly strategic addition to Stereotaxis, amplifying and accelerating our strategy as the leading robotic platform for the broad spectrum of endovascular procedures."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/stereotaxis-to-acquire-robocath/), 2026-04-16: "Stereotaxis has agreed to acquire smart robotic solutions developer Robocath in a deal worth up to $45m."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.